Gilead's Remdesivir Cuts Risk of COVID-19 Death by 62% -- Maybe
There's a major caveat to the claim.
Full Article
Gilead's Remdesivir Cuts Risk of COVID-19 Death by 62% -- Maybe
Motley Fool
0 shares
1 views
You might like
Related news coverage
S&P 500 slides on California reopening rollback after briefly erasing post-COVID losses
Business Insider
· *US stocks slid on Monday, erasing earlier gains, as the governor of California announced closures of bars and indoor dining,..
Dow climbs 230 points as investors gear up for earnings season
Business Insider
Advertisement
More coverage
Stocks recover after selloff as Gilead says remdesivir can reduce risk of death for COVID-19 patients
Stocks bounced back Friday following a sharp selloff, as upbeat news about a potential coronavirus treatment helped mitigate..
USATODAY.com